Armed with cash, Bel­gian iP­SC play­er makes a play for Celyad’s cell ther­a­py man­u­fac­tur­ing site

A Bel­gian cell ther­a­py play­er has net­ted a deal close to home.

Ncar­dia, a Bel­gium-based con­tract re­search com­pa­ny, spun out its cell ther­a­py and man­u­fac­tur­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER